Located in Milwaukee, Wisconsin, the Versiti Blood Research Institute (VBRI) is the largest blood-focused research institute in the United States. With over 30 basic, translational, and clinical researchers, the institute is dedicated to advancing scientific knowledge and developing innovative therapies related to blood and blood disorders. The institute's research interests encompass a wide range of topics, including transfusion medicine, cellular therapy, thrombosis/hemostasis, immunology, and hematologic malignancies. As a vital part of Versiti, a non-profit organization with a blood bank at its core, the VBRI strives to improve lives through innovative research and the development of novel diagnostics and treatments.
VBRI is part of the Milwaukee Regional Medical Campus, a rapidly growing clinical-translational research hub. VBRI’s proximity to the Medical College of Wisconsin, Childrens’ Hospital of Wisconsin, and Froedtert Hospital facilitates seamless interdisciplinary collaborations. A range of exemplary core facilities support highly competitive research. In the summer of 2024, construction of a new research building will start, doubling existing VBRI research space to enable the recruitment of 10-15 new faculty. With its renowned researchers, strategic expansion plans and location in a highly collaborative environment, the VBRI is poised to maintain and expand its position as one of the leading hematology institutes in the world.
Under the direction of Principal Investigator (PI), this position is responsible for coordinating and administratively supporting research programs. This senior position will assist the PI with preparation of manuscripts and applications for funding, post-award management, and coordinating lab-based and clinical research programs. Appropriately qualified candidates will have the opportunity to dedicate up part of their effort to benchwork focused on generating preliminary data to support new applications for funding.
The Deininger lab expertise is in the translational research of leukemia. The lab's research program focuses on the biology of myeloproliferative neoplasms and the development of molecular targeted therapies. We are especially interested in developing novel anti-neoplastic targeted therapies in myeloid leukemia, as well as understanding the molecular mechanisms of cancer stem cell persistence and leukemia drug resistance.
Our lab orchestrates a multi-disciplinary cancer research program, straddling genetics, biochemistry, molecular biology, pharmacology, and biomedical engineering. We are proud of our vibrant team of scientists who strive to improve the diagnosis, deep analysis, and therapeutics of myeloid leukemia.
Education
Experience
Required experience in the field
Knowledge, Skills and Abilities
Licenses and Certifications
Tools and Technology
#LI-RM1
#LI-Onsite
#VBRI